James T. Ogle
No más puestos en curso
Perfil
James T.
Ogle served as Chairman and CEO of Syneos Health NC LLC from 2012 to 2013.
He was also President and CEO of BRI International, Inc. Additionally, he served as Chairman of INC Research Holdings, Inc. from 2003 to 2016 and Chairman of Syneos Health, Inc. from 2013 to 2016.
Ogle was a Director at Kendle International LLC and OpGen, Inc. He also served as Chief Operating Officer at Nascent Pharmaceuticals, Inc. and as a Principal in The United States Army (District of Columbia).
Ogle received his undergraduate degree from the US Military Academy and his graduate degree from The University of Alabama.
Antiguos cargos conocidos de James T. Ogle.
Empresas | Cargo | Fin |
---|---|---|
INC Research Holdings, Inc.
INC Research Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services INC Research Holdings, Inc. engages in the clinical research on therapeutic alignment and expertise in Central Nervous System, Oncology, and other complex diseases. It operates through the Clinical Development Services and Phase I Services segments. The Clinical Development Services segments offers a variety of select and stand-alone clinical development services such as clinical monitoring, investigator recruitment, patient recruitment, data management and study reports to assist customers with their drug development process. The Phase I Services segment focuses on clinical development services for Phase I trials that include scientific exploratory medicine, first-in-human studies through proof-of-concept stages and support for Phase I studies in established compounds. The company was founded on August 13, 2010 and is headquartered in Raleigh, NC. | Presidente | 31/05/2016 |
SYNEOS HEALTH, INC. | Director Ejecutivo | 01/01/2013 |
Kendle International LLC
Kendle International LLC Miscellaneous Commercial ServicesCommercial Services Kendle International LLC provides research and development services to biopharmaceutical companies by offering value-added clinical research services and proprietary information technology. The company was founded in 1981 and is headquartered in Cincinnati, OH. | Director/Miembro de la Junta | 26/07/2011 |
The United States Army (District of Columbia) | Corporate Officer/Principal | - |
BRI International, Inc.
BRI International, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Quintiles Transnational Corp., BRI International, Inc. is a pharmaceutical research and development company with 445 employees. The company is based in Arlington, VA. BRI International was acquired by Quintiles Transnational Corp. on November 22, 1996 for $130.63 million. The company was founded by Harold Solomon. | Presidente | - |
Formación de James T. Ogle.
The University of Alabama | Graduate Degree |
US Military Academy | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
OPGEN, INC. | Commercial Services |
Empresas privadas | 7 |
---|---|
Syneos Health NC LLC
Syneos Health NC LLC Miscellaneous Commercial ServicesCommercial Services Syneos Health LLC operates therapeutically focused global contract research organization. It provides pharma and biotech services. The firm specializes in the hematology, immunology and inflammation infectious diseases, oncology, ophthalmology, cardiovascular, CNS analgesia, CNS neurology, CNS psychiatry, endocrinology, and gastroenterology and hepatology. The company was founded by Kenneth A. Selzer in 1985 and is headquartered in Raleigh, NC. | Commercial Services |
Nascent Pharmaceuticals, Inc.
Nascent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nascent Pharmaceuticals, Inc. manufactured pharmaceuticals and drugs. The company was founded by Charles P. R. de C. du Mée and Gene Barnett in 1999 and was headquartered in Durham, NC. | Health Technology |
BRI International, Inc.
BRI International, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Quintiles Transnational Corp., BRI International, Inc. is a pharmaceutical research and development company with 445 employees. The company is based in Arlington, VA. BRI International was acquired by Quintiles Transnational Corp. on November 22, 1996 for $130.63 million. The company was founded by Harold Solomon. | Commercial Services |
The United States Army (District of Columbia) | Government |
Kendle International LLC
Kendle International LLC Miscellaneous Commercial ServicesCommercial Services Kendle International LLC provides research and development services to biopharmaceutical companies by offering value-added clinical research services and proprietary information technology. The company was founded in 1981 and is headquartered in Cincinnati, OH. | Commercial Services |
INC Research Holdings, Inc.
INC Research Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services INC Research Holdings, Inc. engages in the clinical research on therapeutic alignment and expertise in Central Nervous System, Oncology, and other complex diseases. It operates through the Clinical Development Services and Phase I Services segments. The Clinical Development Services segments offers a variety of select and stand-alone clinical development services such as clinical monitoring, investigator recruitment, patient recruitment, data management and study reports to assist customers with their drug development process. The Phase I Services segment focuses on clinical development services for Phase I trials that include scientific exploratory medicine, first-in-human studies through proof-of-concept stages and support for Phase I studies in established compounds. The company was founded on August 13, 2010 and is headquartered in Raleigh, NC. | Commercial Services |
Syneos Health, Inc.
Syneos Health, Inc. BiotechnologyHealth Technology Syneos Health, Inc. engages in the provision of biopharmaceutical solutions. It operates through the Clinical Solutions and Commercial Solutions segments. The Clinical Solutions segment offers global services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics that span Phase I to IV of clinical development. It also offers individual services including regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health services, clinical trial diversity, biometrics, and regulatory affairs. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, and consultancy services. The company was founded in 1998 and is headquartered in Morrisville, NC. | Health Technology |
- Bolsa de valores
- Insiders
- James T. Ogle